重组Anti-RIG-I/DDX58抗体[EPR18629]
Anti-RIG-I/DDX58 antibody [EPR18629]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
4
(1 Review)
|
(22 Publications)
Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) is a rabbit monoclonal antibody detecting RIG-I/DDX58 in Western Blot, IP. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
查看别名
DDX58, RIGI, Antiviral innate immune response receptor RIG-I, ATP-dependent RNA helicase DDX58, DEAD box protein 58, RIG-I-like receptor 1, RNA sensor RIG-I, Retinoic acid-inducible gene 1 protein, Retinoic acid-inducible gene I protein, RLR-1, RIG-1, RIG-I
- IP
Supplier Data
Immunoprecipitation - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
RIG-I/DDX58 was immunoprecipitated from 1mg of Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate with ab180675 at 1/100 dilution. Western blot was performed from the immunoprecipitate using ab180675 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : Jurkat whole cell lysate 10ug (Input). Lane 2 : ab180675 IP in Jurkat whole cell lysate. Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab180675 in Jurkat whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds.
All lanes:
Immunoprecipitation - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675)
Predicted band size: 107 kDa
false
- WB
Supplier Data
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
All lanes:
Human stomach lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 107 kDa
Observed band size: 107 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Lanes 1 - 2 : Merged signal (red and green). Green - ab180675 observed at 107 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab180675 was shown to react with DDX58 in wild-type A549 cells in western blot with loss of signal observed in DDX58 knockout cell line ab267116 (DDX58 knockout cell lysate ab257916). Wild-type and DDX58 knockout A549 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab180675 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
DDX58 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human DDX58 (RIG-I) knockout A549 cell line (<a href='/products/cell-lines/human-ddx58-rig-i-knockout-a549-cell-line-ab267116'>ab267116</a>)
Predicted band size: 107 kDa
Observed band size: 107 kDa
false
- WB
Lab
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Lanes 1 - 2 : Merged signal (red and green). Green - ab180675 observed at 107 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55kDa.
ab180675 was shown to react with DDX58 in A549 wild-type cells in western blot with loss of signal observed in DDX58 knockout cell line ab267117 (DDX58 knockout cell lysate ab257917). Wild-type and DDX58 knockout A549 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab180675 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
DDX58 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human DDX58 (RIG-I) knockout A549 cell line (<a href='/products/cell-lines/human-ddx58-rig-i-knockout-a549-cell-line-ab267117'>ab267117</a>)
Predicted band size: 107 kDa
Observed band size: 107 kDa
false
- WB
Lab
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : RIG-I/DDX58 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : K562 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab180675 observed at 107 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab180675 was shown to specifically react with RIG-I/DDX58 when RIG-I/DDX58 knockout samples were used. Wild-type and RIG-I/DDX58 knockout samples were subjected to SDS-PAGE. ab180675 and ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675)
Predicted band size: 107 kDa
false
- WB
Supplier Data
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
All lanes:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/10000 dilution
Predicted band size: 107 kDa
Observed band size: 107 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
All lanes:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 107 kDa
Observed band size: 107 kDa
false
Exposure time: 1min
- WB
Supplier Data
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) at 1/1000 dilution
Lane 1:
293 (Human epithelial cells from embryonic kidney) whole cell lysate at 10 µg
Lane 2:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 107 kDa,34 kDa
Observed band size: 107 kDa,34 kDa
false
Exposure time: 3min
- WB
CiteAb
Western blot - Anti-RIG-I/DDX58 antibody [EPR18629] (AB180675)
RIG-I/DDX58 western blot using anti-RIG-I/DDX58 antibody [EPR18629] ab180675. Publication image and figure legend from Zhao, Y., Ye, X., et al., 2018, Nat Commun, PubMed 30451863.
ab180675 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab180675 please see the product overview.
RLRs-MAVS signaling pathway restricts KSHV lytic reactivation in BC-3 cells. a RNA was extracted from BC-3 cells expressing the indicated shRNAs and the target mRNA level was quantified by RT-qPCR. b Expression of KSHV viral genes in cells described in (a) was quantified by RT- qPCR. c BC-3 F-RIG-I, F-MDA5, and Control (Con) cells were reactivated for 48 h. Cell lysates from latent and lytic cells were analyzed by immunoblot for the indicated proteins. d RNA was extracted from BC-3 cells described in (c) and expression of the indicated viral genes was quantified by RT-qPCR. Error bars in all panels represent mean ± SD from three independent experiments. p-values were determined by the Student's t test, *p < 0.05, **p < 0.01
false
不同偶联物与剂型 (1)
-
Anti-RIG-I/DDX58 antibody [EPR18629] - BSA and Azide free
反应性数据
产品详情
What is this antibody validated in?
Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP) in Human samples.
What is the molecular weight of RIG-I/DDX58?
Anti-RIG-I/DDX58 [EPR18629] (ab180675) specifically detects a band for RIG-I/DDX58 (UniProt: O95786) at a molecular weight of 107kDa.
Trusted by the scientific community
Anti-RIG-I/DDX58 [EPR18629] (ab180675) was first used in a scientific publication in 2015 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-RIG-I/DDX58 antibody [EPR18629] (ab180675) has been confirmed by Western blot testing in RIGI Knockout HAP1 cell line, ab267117.
Other related products
We have a range of other formats of antibody clone [EPR18629] also available for your convenience: ab180675, Carrier free - ab240230
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIG-I contributes significantly to the innate immune response. It acts to sense viral RNA and triggers the production of type I interferons and other pro-inflammatory cytokines. This protein functions as part of a complex that includes MAVS (mitochondrial antiviral signaling protein) and other signaling adapters. Upon activation RIG-I undergoes a conformational change leading to the exposure of its CARDs which interact with CARDs of MAVS facilitating downstream signaling to induce an antiviral state in host cells.
Pathways
RIG-I plays a central role in the RNA sensing pathway critical for antiviral immunity. This pathway involves several steps beginning with the recognition of viral RNA leading to the activation of interferon regulatory factors like IRF3 and IRF7 as well as nuclear factor kappa B (NF-κB). These factors then promote the expression of interferon-stimulated genes (ISGs). RIG-I also relates closely to the Jak-STAT signaling pathway which is activated by interferons and enhances the transcription of ISGs further amplifying the antiviral response.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (22)
Recent publications for all applications. Explore the full list and refine your search
Autophagy 20:2133-2145 PubMed38762760
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed38334619
2024
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 58:2495-2509.e6 PubMed37683630
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature 619:811-818 PubMed37407817
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature 614:358-366 PubMed36725932
2023
Applications
Unspecified application
Species
Unspecified reactive species
Diabetes, metabolic syndrome and obesity : targets and therapy 15:3069-3080 PubMed36237968
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of virology 96:e0077622 PubMed36069546
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:104607 PubMed35800772
2022
Applications
Unspecified application
Species
Unspecified reactive species
Liver international : official journal of the International Association for the Study of the Liver 42:1676-1691 PubMed35460174
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 31:1165-1176 PubMed35332586
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com